BridgeBio has demonstrably improved the progress of an innovative solution for ATTR-CM, leveraging the compound. Initial patient results reveals promising outcomes for those diagnosed by a debilitating disease. The focus highlights the company’s commitment to addressing significant healthcare requirements in a heart disease field. Attru… Read More